Bristol Myers Squibb BMY
NYSE BMY
$67.29 +1.82 (+2.77%)
As of: Aug 21, 2026 · 11:29 AM EDT

Bristol Myers Squibb Co (BMY) Operating Margin (2009 - 2026)

Bristol Myers Squibb (BMY) posted quarterly Operating Margin of 2.77% for Q2 2026, up 1581.0% year-over-year from 0.17% in Q2 2025, and up 275.18% quarter-over-quarter from 1.58% in Q1 2026.

Bristol Myers Squibb Co (BMY) Operating Margin (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (BMY) has reported Operating Margin for 18 consecutive years, with 2.77% the latest figure, recorded in Q2 2026.

  • In Q2 2026, Operating Margin rose 1581.0% year-over-year to 2.77%; the TTM figure through Jun 2026 stood at 5.63% (up 1026.0% YoY), while the FY2025 annual figure was 9.56%, up 3671.0% from the prior year.
  • Operating Margin climbed to 2.77% in Q2 2026 per BMY's latest filing, from 1.58% in the prior quarter.
  • Across five years, Operating Margin topped out at 2.77% in Q2 2026 and bottomed at 121.77% in Q1 2024.
  • Historically, Operating Margin has averaged 14.62% across 5 years, with a median of 6.58% in 2022.
  • Annual changes were most pronounced in 2024 — Operating Margin slumped 12357 bps — and 2025, when it surged 12122 bps.
  • Bristol Myers Squibb's Operating Margin stood at 6.44% in 2022, then sank by 45 bps to 9.33% in 2023, then slumped by 303 bps to 37.57% in 2024, then soared by 44 bps to 21.01% in 2025, then surged by 113 bps to 2.77% in 2026.
  • Business Quant data shows BMY's Operating Margin at 2.77% in Q2 2026, 1.58% in Q1 2026, and 21.01% in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 2.77%
Mar 31, 2026 -1.58%
Dec 31, 2025 -21.01%
Sep 30, 2025 -2.63%
Jun 30, 2025 -13.03%
Mar 31, 2025 -0.55%
Dec 31, 2024 -37.57%
Sep 30, 2024 -10.77%
Jun 30, 2024 -16.24%
Mar 31, 2024 -121.77%
Dec 31, 2023 -9.33%
Sep 30, 2023 -3.36%
Jun 30, 2023 -9.06%
Mar 31, 2023 1.80%
Dec 31, 2022 -6.44%
Sep 30, 2022 -1.28%
Jun 30, 2022 -6.41%
Mar 31, 2022 -6.73%
Dec 31, 2021 -4.16%
Sep 30, 2021 -1.15%